ADVANCED PANCREATIC CANCERS
Clinical trials for ADVANCED PANCREATIC CANCERS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC CANCERS trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Patient's own immune cells fight tough cancers?
Disease control Recruiting nowThis early-phase trial is testing a treatment called tumor-infiltrating lymphocytes (TILs) in 50 people with advanced liver or pancreatic cancers that have not responded to standard treatments. Doctors take immune cells from a patient's tumor, grow them in a lab, and then infuse …
Matched conditions: ADVANCED PANCREATIC CANCERS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for pancreatic cancer: targeted drug combo enters Mid-Stage trial
Disease control Recruiting nowThis phase II study tests a new drug called IBI343, which targets a protein on cancer cells, combined with standard chemotherapy (gemcitabine and albumin-bound paclitaxel) in 64 people with advanced pancreatic cancer. The trial has two parts: a safety lead-in and a randomized ext…
Matched conditions: ADVANCED PANCREATIC CANCERS
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New combo tackles cancer pain and tumors at once
Symptom relief Recruiting nowThis study is for people with advanced bile duct or pancreatic cancer who have significant pain. Researchers want to see if adding a nerve-blocking pain treatment (celiac plexus block) to standard first-line cancer therapy helps control pain and shrink tumors better than standard…
Matched conditions: ADVANCED PANCREATIC CANCERS
Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC